Naringenin Attenuates Myocardial Ischemia-Reperfusion Injury via cGMP-PKGIα Signaling and In Vivo and In Vitro Studies
Open Access
- 8 January 2019
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2019, 1-15
Abstract
Endoplasmic reticulum (ER) stress and oxidative stress contribute greatly to myocardial ischemia-reperfusion (MI/R) injury. Naringenin, a flavonoid derived from the citrus genus, exerts cardioprotective effects. However, the effects of naringenin on ER stress as well as oxidative stress under MI/R condition and the detailed mechanisms remain poorly defined. This study investigated the protective effect of naringenin on MI/R-injured heart with a focus on cyclic guanosine monophosphate- (cGMP-) dependent protein kinase (PKG) signaling. Sprague-Dawley rats were treated with naringenin (50 mg/kg/d) and subjected to MI/R surgery with or without KT5823 (2 mg/kg, a selective inhibitor of PKG) cotreatment. Cellular experiment was conducted on H9c2 cardiomyoblasts subjected to simulated ischemia-reperfusion treatment. Before the treatment, the cells were incubated with naringenin (80 μmol/L). PKGIα siRNA was employed to inhibit PKG signaling. Our in vivo and in vitro data showed that naringenin effectively improved heart function while it attenuated myocardial apoptosis and infarction. Furthermore, pretreatment with naringenin suppressed MI/R-induced oxidative stress as well as ER stress as evidenced by decreased superoxide generation, myocardial MDA level, gp91phox expression, and phosphorylation of PERK, IRE1α, and EIF2α as well as reduced ATF6 and CHOP. Importantly, naringenin significantly activated myocardial cGMP-PKGIα signaling while inhibition of PKG signaling with KT5823 (in vivo) or siRNA (in vitro) not only abolished these actions but also blunted naringenin’s inhibitory effects against oxidative stress and ER stress. In summary, our study demonstrates that naringenin treatment protects against MI/R injury by reducing oxidative stress and ER stress via cGMP-PKGIα signaling. Its cardioprotective effect deserves further clinical study.Keywords
Funding Information
- Natural Science Foundation of Liaoning Province (20170540973, 81570232, 81470411, 81500263, 81700264)
- National Natural Science Foundation of China (20170540973, 81570232, 81470411, 81500263, 81700264)
- National Natural Science Foundation of China (20170540973, 81570232, 81470411, 81500263, 81700264)
- National Natural Science Foundation of China (20170540973, 81570232, 81470411, 81500263, 81700264)
- National Natural Science Foundation of China (20170540973, 81570232, 81470411, 81500263, 81700264)
This publication has 72 references indexed in Scilit:
- Supplemental Naringenin Prevents Intestinal Barrier Defects and Inflammation in Colitic MiceThe Journal of Nutrition, 2013
- Essential role of nitric oxide in acute ischemic preconditioning: S-Nitros(yl)ation versus sGC/cGMP/PKG signaling?Free Radical Biology and Medicine, 2013
- IRAG and novel PKG targeting in the cardiovascular systemAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- cGMP/PKG pathway mediates myocardial postconditioning protection in rat hearts by delaying normalization of intracellular acidosis during reperfusionJournal of Molecular and Cellular Cardiology, 2011
- Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia/reoxygenationBasic Research in Cardiology, 2010
- Hyperlipidaemia induced by a high‐cholesterol diet leads to the deterioration of guanosine‐3′,5′‐cyclic monophosphate/protein kinase G‐dependent cardioprotection in ratsBritish Journal of Pharmacology, 2009
- Effects of pink grapefruit juice on QT variability in patients with dilated or hypertensive cardiomyopathy and in healthy subjectsTranslational Research, 2008
- Cardioprotection: spotlight on PKGBritish Journal of Pharmacology, 2007
- Endoplasmic reticulum stress: cell life and death decisionsJournal of Clinical Investigation, 2005
- Implication of Cyclic Nucleotide Phosphodiesterase Inhibition in the Vasorelaxant Activity of the Citrus-Fruits Flavonoid (±)-NaringeninPlanta Medica, 2005